Evidence map›Paper›PMID 24416334›Full record

ArticlePloS one2014

Age-dependent relevance of endogenous 5-lipoxygenase derivatives in anxiety-like behavior in mice.

Luciana M Leo, Suellen Almeida-Corrêa, Claudio A Canetti, Olavo B Amaral, Fernando A Bozza, Fabricio A Pamplona

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Reduced Oligodendrocyte Precursor Cell Impairs Astrocytic Development in Early Life Stress.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Constructing an Inexpensive Elevated Plus Maze.Journal of undergraduate neuroscience education : JUNE : a publication of FUN, Faculty for Undergraduate Neuroscience · 2018
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Luciana M LeoD'Or Institute for Research and Education, Rio de Janeiro, Brazil ; Lab. Immunopharmacology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Suellen Almeida-CorrêaLab. Neurobiology of Memory, Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil ; National Center for Bioimaging (CENABIO), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Claudio A CanettiLab. Inflammation, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Olavo B AmaralLab. Neurobiology of Memory, Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil ; National Center for Bioimaging (CENABIO), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Fernando A BozzaD'Or Institute for Research and Education, Rio de Janeiro, Brazil ; Lab. Immunopharmacology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Fabricio A PamplonaD'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal do Rio de Janeiro · BRD’Or Institute for Research and Education · BRNational Institute of Science and Technology for Structural Biology and Bioimaging · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When 5-lipoxygenase (5-LO) is inhibited, roughly half of the CNS effect of the prototypic endocannabinoid anandamide (AEA) is lost. Therefore, we decided to investigate whether inhibiting this enzyme would influence physiological functions classically described as being under control of the endocannabinoid system. Although 5-LO inhibition by MK-886 reduced lipoxin A4 levels in the brain, no effect was found in the elevated plus maze (EPM), even at the highest possible doses, via i.p. (10 mg/kg,) or i.c.v. (500 pmol/2 µl) routes. Accordingly, no alterations in anxiety-like behavior in the EPM test were observed in 5-LO KO mice. Interestingly, aged mice, which show reduced circulating lipoxin A4 levels, were sensitive to MK-886, displaying an anxiogenic-like state in response to treatment. Moreover, exogenous lipoxin A4 induced an anxiolytic-like profile in the EPM test. Our findings are in line with other reports showing no difference between FLAP KO or 5-LO KO and their control strains in adult mice, but increased anxiety-like behavior in aged mice. We also show for the first time that lipoxin A4 affects mouse behavior. In conclusion, we propose an age-dependent relevancy of endogenous 5-LO derivatives in the modulation of anxiety-like behavior, in addition to a potential for exogenous lipoxin A4 in producing an anxiolytic-like state.

Indexed as

5-Lipoxygenase-Activating ProteinsAge FactorsAnimalsAnti-Anxiety AgentsAnxietyArachidonate 5-LipoxygenaseArachidonic AcidsBrainCannabinoid Receptor AgonistsChlorobenzenesEndocannabinoidsIndolesInjections, IntraperitonealInjections, IntraventricularLipoxinsLipoxygenase Inhibitors5-Lipoxygenase-Activating ProteinsAlox5ap protein, mouseanandamideAnti-Anxiety AgentsArachidonate 5-LipoxygenaseArachidonic AcidsCannabinoid Receptor AgonistsChlorobenzenesEndocannabinoidsIndoleslipoxin A4LipoxinsLipoxygenase InhibitorsMK-886Polyunsaturated Alkamides

Identifiers

PMID24416334
PMCPMC3885659
OpenAlexW2068338750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.